Lilly presents new data from the UNCOVER-2 trial of ixekizumab
8 March 2016 | By Victoria White
In UNCOVER-2, patients with plaque psoriasis who did not respond to etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab...